Home › Metastatic Cancer › Louisiana › Baton Rouge
Pag-aaral pangklinika para sa Metastatic Cancer sa Baton Rouge, LA
9 pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Baton Rouge (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Nagre-recruitPhase 3
- Research Site, Baton Rouge
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- Our Lady of the Lake RMC, Baton Rouge
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Nagre-recruitPhase 1/2
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- Mary Bird Perkins Cancer Center, Baton Rouge
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Our Lady of the Lake, Baton Rouge
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Nagre-recruitPhase 1/2
- Mary Bird Perkins Cancer Center, Baton Rouge
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 3
- Mary Bird Perkins Cancer Center, Baton Rouge
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- St. Louis, MO54 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
Iba pang pag-aaral sa Baton Rouge
- Obesity15 pag-aaral
- Overweight10 pag-aaral
- Non-Small Cell Lung Cancer10 pag-aaral
- Acute Myeloid Leukemia8 pag-aaral
- Kanser sa Baga8 pag-aaral
- Colorectal Cancer8 pag-aaral
- Kanser sa Suso7 pag-aaral
- Kanser sa Pantog6 pag-aaral
- Chronic Lymphocytic Leukemia5 pag-aaral
- Kanser sa Prostate5 pag-aaral
- COPD5 pag-aaral
- Pagkabigo ng Puso5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.